Gene · 4921
Papers2,653
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
881 to 900 of 2,653
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Cancer-Associated Fibroblast Heterogeneity: A Factor That Cannot Be Ignored in Immune Microenvironment Remodeling. | Front Immunol | 2021 | 34305902 | PubTator, text mining | PubMed |
| Sequencing of a central nervous system tumor demonstrates cancer transmission in an organ transplant. | Life Sci Alliance | 2021 | 34301805 | PubTator, text mining | PubMed |
| Immune Microenvironment Features and Dynamics in Hodgkin Lymphoma. | Cancers (Basel) | 2021 | 34298847 | PubTator, text mining | PubMed |
| Resectable Colorectal Cancer: Current Perceptions on the Correlation of Recurrence Risk, Microbiota and Detection of Genetic Mutations in Liquid Biopsies. | Cancers (Basel) | 2021 | 34298740 | PubTator, text mining | PubMed |
| Autocrine signaling by receptor tyrosine kinases in urothelial carcinoma of the bladder. | PLoS One | 2021 | 34292953 | PubTator, text mining | PubMed |
| Bbc3 Loss Enhances Survival and Protein Clearance in Neurons Exposed to the Organophosphate Pesticide Chlorpyrifos. | Toxicol Sci | 2021 | 34289071 | PubTator, text mining | PubMed |
| scDPN for High-throughput Single-cell CNV Detection to Uncover Clonal Evolution During HCC Recurrence. | Genomics Proteomics Bioinformatics | 2021 | 34280548 | PubTator, text mining | PubMed |
| Lost bones: differential diagnosis of acro-osteolysis seen by the pediatric rheumatologist. | Pediatr Rheumatol Online J | 2021 | 34261502 | PubTator, text mining | PubMed |
| Investigation of the specificity and mechanism of action of the ULK1/AMPK inhibitor SBI-0206965. | Biochem J | 2021 | 34259310 | PubTator, text mining | PubMed |
| Mutation Spectrum of EGFR From 21,324 Chinese Patients With Non-Small Cell Lung Cancer (NSCLC) Successfully Tested by Multiple Methods in a CAP-Accredited Laboratory. | Pathol Oncol Res | 2021 | 34257561 | PubTator, text mining | PubMed |
| Hybrid Capture-based Genomic Profiling of Circulating Tumor DNA From Patients With Advanced Ovarian Cancer. | Pathol Oncol Res | 2021 | 34257528 | PubTator, text mining | PubMed |
| Identification of potential micro-messenger RNAs (miRNA-mRNA) interaction network of osteosarcoma. | Bioengineered | 2021 | 34252359 | PubTator, text mining | PubMed |
| Prognostic value of the PrPC-ILK-IDO1 axis in the mesenchymal colorectal cancer subtype. | Oncoimmunology | 2021 | 34249475 | PubTator, text mining | PubMed |
| Can Discord Domain-Containing Receptor 2 Mutation Act as a Disease Modifier for PRKAR1A Associated Melanotic Schwannoma? | Case Rep Oncol | 2021 | 34248546 | PubTator, text mining | PubMed |
| Identification of methylation-driven genes prognosis signature and immune microenvironment in uterus corpus endometrial cancer. | Cancer Cell Int | 2021 | 34246261 | PubTator, text mining | PubMed |
| DDR1-induced neutrophil extracellular traps drive pancreatic cancer metastasis. | JCI Insight | 2021 | 34237033 | PubTator, text mining | PubMed |
| SPP1 overexpression is associated with poor outcomes in ALK fusion lung cancer patients without receiving targeted therapy. | Sci Rep | 2021 | 34234236 | PubTator, text mining | PubMed |
| Transcriptomics unravels molecular players shaping dorsal lip hypertrophy in the vacuum cleaner cichlid, Gnathochromis permaxillaris. | BMC Genomics | 2021 | 34225643 | PubTator, text mining | PubMed |
| Exceptional response to the ALK and ROS1 inhibitor lorlatinib and subsequent mechanism of resistance in relapsed ALK F1174L-mutated neuroblastoma. | Cold Spring Harb Mol Case Stud | 2021 | 34210658 | PubTator, text mining | PubMed |
| Potentiating Therapeutic Effects of Epidermal Growth Factor Receptor Inhibition in Triple-Negative Breast Cancer. | Pharmaceuticals (Basel) | 2021 | 34207383 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/4921/papers?page=45